INT24160

From wiki-pain
Jump to: navigation, search
Context Info
Confidence 0.65
First Reported 1983
Last Reported 2009
Negated 0
Speculated 0
Reported most in Abstract
Documents 7
Total Number 7
Disease Relevance 1.42
Pain Relevance 3.46

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

signal transduction (TRIM13) endoplasmic reticulum (TRIM13) intracellular (TRIM13)
ligase activity (TRIM13) cytoplasm (TRIM13) signal transducer activity (TRIM13)
Anatomy Link Frequency
NG108-15 1
neurons 1
TRIM13 (Homo sapiens)
Pain Link Frequency Relevance Heat
Enkephalin 32 100.00 Very High Very High Very High
Neuropeptide 8 99.56 Very High Very High Very High
Dynorphin 4 99.36 Very High Very High Very High
Kinase C 18 98.32 Very High Very High Very High
Somatostatin 2 97.56 Very High Very High Very High
Glutamate 4 95.84 Very High Very High Very High
substance P 1 92.08 High High
chemokine 2 88.08 High High
narcan 2 83.80 Quite High
opiate 2 79.24 Quite High
Disease Link Frequency Relevance Heat
Cancer 128 99.88 Very High Very High Very High
Breast Cancer 12 95.60 Very High Very High Very High
Paraganglioma 5 92.60 High High
Metastasis 19 90.08 High High
Adenocarcinoma 2 83.56 Quite High
Malignant Neoplastic Disease 5 75.00 Quite High
Solid Tumor 3 60.56 Quite High
Benign Tumor 1 42.32 Quite Low
Glioma 1 33.56 Quite Low
Neuroblastoma 1 33.20 Quite Low

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
Most tumors were positive for [Leu5]-enkephalin (76 per cent), [Met5]-enkephalin (75 per cent), somatostatin (67 per cent), and pancreatic polypeptide (51 per cent), followed by vasoactive intestinal polypeptide (VIP) (43 per cent), substance P (31 per cent), ACTH (28 per cent), calcitonin (23 per cent), bombesin (15 per cent), and neurotensin (12 per cent).
Gene_expression (positive) of Leu5 associated with cancer, somatostatin, enkephalin and substance p
1) Confidence 0.65 Published 1988 Journal Hum. Pathol. Section Abstract Doc Link 2447010 Disease Relevance 0.58 Pain Relevance 0.44
Actions of D-Ala2-D-Leu5-enkephalin and dynorphin A (1-17) on neocortical neurons in vitro.
Gene_expression (Actions) of Leu5 in neurons associated with dynorphin and enkephalin
2) Confidence 0.65 Published 1984 Journal Neuropeptides Section Title Doc Link 6152323 Disease Relevance 0 Pain Relevance 0.74
Application of D-Ala2-D-Leu5-enkephalin (DADL) by different methods produced a decrease in EPSP amplitude and in the amplitude of L-glutamate-induced depolarizations without changes in membrane potential or membrane input resistance.
Gene_expression (Application) of Leu5 associated with glutamate and enkephalin
3) Confidence 0.65 Published 1984 Journal Neuropeptides Section Abstract Doc Link 6152323 Disease Relevance 0 Pain Relevance 0.70
The synthesis, bioactivity and enzyme stability of D-Ala2, EPhe4, Leu5-enkephalins.
Gene_expression (synthesis) of Leu5 associated with enkephalin
4) Confidence 0.65 Published 1983 Journal Biochem. Biophys. Res. Commun. Section Title Doc Link 6615520 Disease Relevance 0 Pain Relevance 0.29
The neuropeptide leucine-enkephalin ([Leu5]-enkephalin) has been covalently labelled with the two organometallic Mo carbonyl complexes Mo(R-His)(allyl)(CO)2 (His = N delta,N,O-L-histidinate) and Mo(R-bpa)(CO)3 (bpa = bis(2-picolyl)a-mine) on the resin as the last step of a solid-phase synthesis scheme and in solution.
Gene_expression (labelled) of Leu5 associated with neuropeptide and enkephalin
5) Confidence 0.65 Published 2002 Journal Chem. Commun. (Camb.) Section Abstract Doc Link 12125577 Disease Relevance 0 Pain Relevance 0.32
The presence of both Met5- and Leu5-enkephalin-like activities in NG108-15 cells was confirmed in acid extracts of cells by radioreceptor assay after separation by reverse phase high pressure liquid chromatography.
Gene_expression (presence) of Leu5 in NG108-15 associated with enkephalin
6) Confidence 0.58 Published 1983 Journal J. Neurosci. Section Abstract Doc Link 6193253 Disease Relevance 0 Pain Relevance 0.58
to a monomeric red fluorescent protein (mRFP1) and introduced this fusion protein into the mammary cells already stably expressing CXCR4-GFP.
Gene_expression (introduced) of mRFP1
7) Confidence 0.01 Published 2009 Journal Target Oncol Section Body Doc Link PMC2778706 Disease Relevance 0.83 Pain Relevance 0.38

General Comments

This test has worked.

Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox